Evidence map›Paper›PMID 38979812›Full record

Observational studyJournal of the American Heart Association2024

CLEAR Thrombectomy Score: An Index to Estimate the Probability of Good Functional Outcome With or Without Endovascular Treatment in the Late Window for Anterior Circulation Occlusion.

James E Siegler, Manisha Koneru, Muhammad M Qureshi, Mohamed Doheim, Raul G Nogueira, Nicolas Martinez-Majander, Simon Nagel, Mary Penckofer, Jelle Demeestere, Volker Puetz and 50 more

Registry-linked trialAbstract readObservational StudyMulticenter Study
In one paragraph

Observational study in Journal of the American Heart Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04096248 (Non-Contrast CT vs CTP or MRI Selection vs Medical Management in Late Presentation of Large Vessel Occlusion Stroke, 6-24 Hours. A Multicenter Retrospective Study), which is not on this map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04096248 completednot on this map

Non-Contrast CT vs CTP or MRI Selection vs Medical Management in Late Presentation of Large Vessel Occlusion Stroke, 6-24 Hours. A Multicenter Retrospective Study

TypeobservationalSponsorBoston Medical CenterRan2020 to 2022Enrolled2,790ConditionsStroke, Cardiovascular
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

60 authors.

James E SieglerUniversity of Chicago Medical Center Chicago IL USA.ORCID 0000-0003-0287-3967
Manisha KoneruCooper Medical School of Rowan University Camden NJ USA.ORCID 0000-0001-5012-6793
Muhammad M QureshiRadiology, Radiation Oncology Boston Medical Center Boston MA USA.ORCID 0000-0002-2056-3308
Mohamed DoheimUniversity of Pittsburgh Medical Center Pittsburgh PA USA.
Raul G NogueiraUniversity of Pittsburgh Medical Center Pittsburgh PA USA.ORCID 0000-0003-4532-153X
Nicolas Martinez-MajanderNeurology, Helsinki University Hospital Helsinki Finland.ORCID 0000-0001-8489-7051
Simon NagelNeurology Klinikum Ludwigshafen Ludwigshafen Germany.ORCID 0000-0003-2471-6647
Mary PenckoferCooper Medical School of Rowan University Camden NJ USA.ORCID 0000-0002-7192-8557
Jelle DemeestereNeurology Leuven University Hospital Leuven Belgium.ORCID 0000-0001-8186-0237
Volker PuetzNeurology University Hospital Carl Gustav Carus Dresden Germany.ORCID 0000-0003-1415-3027
Marc RiboNeurology Hospital Vall d'Hebron Barcelona Spain.ORCID 0000-0001-9242-043X
Mohamad AbdalkaderRadiology Boston Medical Center Boston MA USA.
João Pedro MartoNeurology Hospital de Egas Moniz, Centro Hospitalar Lisboa Ocidental Lisbon Portugal.ORCID 0000-0003-2277-5950
Alhamza R Al-BayatiUniversity of Pittsburgh Medical Center Pittsburgh PA USA.ORCID 0000-0001-8103-1930
Hiroshi YamagamiStroke Prevention and Treatment Institute of Medicine, University of Tsukuba Japan.ORCID 0000-0001-8133-3314
Diogo C HaussenNeurology Grady Memorial Hospital Atlanta GA USA.ORCID 0000-0003-1884-2196
Marta Olive-GadeaNeurology Hospital Vall d'Hebron Barcelona Spain.ORCID 0000-0003-4637-1598
Simon WinzerNeurology University Hospital Carl Gustav Carus Dresden Germany.ORCID 0009-0005-1757-753X
Mahmoud H MohammadenNeurology Grady Memorial Hospital Atlanta GA USA.ORCID 0000-0002-7393-9989
Robin LemmensNeurology Leuven University Hospital Leuven Belgium.ORCID 0000-0002-4948-5956
Kanta TanakaDivision of Stroke Care Unit National Cerebral and Cardiovascular Center Suita Japan.ORCID 0000-0002-3291-5083
Pekka VirtanenRadiology Helsinki University Hospital Helsinki Finland.ORCID 0000-0002-9547-4940
Anne DusartNeurology Hôpital Civil Marie Curie Charleroi Belgium.ORCID 0009-0004-9988-2783
Flavio BellanteNeurology Hôpital Civil Marie Curie Charleroi Belgium.
Daniel P O KaiserDresden Neurovascular Center University Hospital Carl Gustav Carus Dresden Germany.ORCID 0000-0001-5258-0025
Francois CaparrosNeurology Centre Hospitalier Universitaire de Lille Lille France.ORCID 0000-0002-6627-0893
Hilde HenonNeurology Centre Hospitalier Universitaire de Lille Lille France.ORCID 0000-0001-6274-7562
João Nuno RamosNeuroradiology Hospital de Egas Moniz, Centro Hospitalar Lisboa Ocidental Lisbon Portugal.ORCID 0000-0001-9678-3422
Santiago Ortega-GutierrezNeurology University of Iowa Hospitals and Clinics Iowa City IA USA.ORCID 0000-0002-3408-1297
Sunil A ShethNeurology UTHealth McGovern Medical School Houston TX USA.ORCID 0000-0003-0602-8509
Stefania NannoniClinical Neurosciences University of Cambridge Cambridge UK.ORCID 0000-0002-1825-1874
Lieselotte VandewalleNeurology Leuven University Hospital Leuven Belgium.ORCID 0000-0002-0375-3804
Johannes KaesmacherInstitute of Diagnostic and Interventional Neuroradiology University Hospital Bern Bern Switzerland.ORCID 0000-0002-9177-2289
Sergio Salazar-MarioniNeurology UTHealth McGovern Medical School Houston TX USA.ORCID 0000-0002-2722-7542
Liisa TomppoNeurology, Helsinki University Hospital Helsinki Finland.ORCID 0000-0002-9369-5846
Rita VenturaNeurology Hospital de Egas Moniz, Centro Hospitalar Lisboa Ocidental Lisbon Portugal.ORCID 0000-0003-0952-3353
Syed F ZaidiNeurology University of Toledo Toledo OH USA.ORCID 0000-0003-4967-1801
Mouhammad JumaaNeurology University of Toledo Toledo OH USA.ORCID 0000-0002-7165-797X
Alicia C CastonguayNeurology University of Toledo Toledo OH USA.ORCID 0000-0003-4738-6767
Milagros Galecio-CastilloNeurology University of Iowa Hospitals and Clinics Iowa City IA USA.ORCID 0000-0002-8107-9632
Ajit S PuriInterventional Neuroradiology University of Massachusetts Memorial Medical Center Worcester MA USA.
Adnan MujanovicInstitute of Diagnostic and Interventional Neuroradiology University Hospital Bern Bern Switzerland.ORCID 0000-0002-6839-7134
Piers KleinRadiology Boston Medical Center Boston MA USA.ORCID 0000-0001-7468-137X
Liqi ShuNeurology Rhode Island Hospital, Brown University Providence RI USA.ORCID 0000-0002-9784-8475
Behzad FarzinRadiology Centre Hospitalier de l'Université de Montréal Montreal QC Canada.ORCID 0000-0003-0420-1005
Hannah MoomeyRadiology Boston Medical Center Boston MA USA.
Hesham E MasoudNeurology State University of New York Syracuse NY USA.ORCID 0000-0002-2796-1499
Jessica JesserNeuroradiology Heidelberg University Hospital Heidelberg Germany.ORCID 0000-0002-1236-8828
Markus A MöhlenbruchNeuroradiology Heidelberg University Hospital Heidelberg Germany.ORCID 0000-0002-5075-704X
Peter A RinglebNeurology Heidelberg University Hospital Heidelberg Germany.ORCID 0000-0002-5473-8671
Daniel StrbianNeurology, Helsinki University Hospital Helsinki Finland.ORCID 0000-0001-9095-2344
Osama O ZaidatNeuroscience and Stroke Program Bon Secours Mercy Health St. Vincent Hospital Toledo OH USA.ORCID 0000-0003-4881-4698
Shadi YaghiNeurology Rhode Island Hospital, Brown University Providence RI USA.ORCID 0000-0003-0031-1004
Davide StramboNeurology Service Lausanne University Hospital and University of Lausanne Lausanne Switzerland.ORCID 0000-0003-4429-2714
Patrik MichelNeurology Service Lausanne University Hospital and University of Lausanne Lausanne Switzerland.ORCID 0000-0003-4954-7579
Daniel RoyRadiology Centre Hospitalier de l'Université de Montréal Montreal QC Canada.ORCID 0000-0002-6066-4453
Shinichi YoshimuraNeurosurgery Hyogo Medical University Nishinomiya Japan.ORCID 0000-0002-3600-4842
Kazutaka UchidaNeurosurgery Hyogo Medical University Nishinomiya Japan.ORCID 0000-0003-4780-9598
Jean RaymondRadiology Centre Hospitalier de l'Université de Montréal Montreal QC Canada.ORCID 0000-0003-1978-4274
Thanh N NguyenRadiology Boston Medical Center Boston MA USA.ORCID 0000-0002-2810-1685

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWith the expanding eligibility for endovascular therapy (EVT) of patients presenting in the late window (6-24 hours after last known well), we aimed to derive a score to predict favorable outcomes associated with EVT versus best medical management. METHODS AND

resultsA multinational observational cohort of patients from the CLEAR (Computed Tomography for Late Endovascular Reperfusion) study with proximal intracranial occlusion (2014-2022) was queried (n=58 sites). Logistic regression analyses were used to derive a 9-point score for predicting good functional outcome (modified Rankin Scale score 0-2 or return to premorbid modified Rankin Scale score) at 90 days, with sensitivity analyses for prespecified subgroups conducted using bootstrapped random forest regressions. Secondary outcomes included 90-day functional independence (modified Rankin Scale score 0-2), poor outcome (modified Rankin Scale score 5-6), and 90-day survival. The score was externally validated with a single-center cohort (2014-2023). Of the 3231 included patients (n=2499 EVT), a 9-point score included age, early computed tomography ischemic changes, and stroke severity, with higher points indicating a higher probability of a good functional outcome. The areas under the curve for the primary outcome among EVT and best medical management subgroups were 0.72 (95% CI, 0.70-0.74) and 0.87 (95% CI, 0.84-0.90), respectively, with similar performance in the external validation cohort (area under the curve, 0.71 [95% CI, 0.66-0.76]). There was a significant interaction between the score and EVT for good functional outcome, functional independence, and poor outcome (all

conclusionsThis score is a pragmatic tool that can estimate the probability of a good outcome with EVT in the late window. REGISTRATION: URL: https://www.Clinicaltrials.gov; Unique identifier: NCT04096248.

Indexed as

Endovascular ProceduresThrombectomyAgedFemaleFunctional StatusHumansIschemic StrokeMaleMiddle AgedPredictive Value of TestsRecovery of FunctionRisk AssessmentTime FactorsTime-to-TreatmentTomography, X-Ray ComputedTreatment Outcomeacute strokeendovascular therapylate windowprognosisscorethrombectomy

Identifiers

PMID38979812
PMCPMC11292751

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.